FDA Mandates Major Opioid Label Revisions to Highlight Long-Term Risks
Pharmacy Times
AUGUST 7, 2025
These changes allow pharmacists to effectively support safer pain management through communication, medication review, and interdisciplinary collaboration, with the final result being better outcomes and reduced opioid-related harm. FDA Requires Major Changes to Opioid Pain Medication Labeling to Emphasize Risks. REFERENCES 1.
Let's personalize your content